Results
245
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
245 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ONON | US$45.90 | 8.1% | 63.6% | US$14.3b | US$46.88 | PE80.8x | E24.4% | n/a | Consumer Durables | ||
ARES | US$146.96 | 1.6% | 45.8% | US$46.0b | US$150.64 | PE77.6x | E32.4% | 2.5% | Diversified Financials | ||
SRPT | US$140.35 | 2.2% | 18.3% | US$13.4b | US$193.59 | PE283x | E44.9% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$126.46 | -2.7% | 170.0% | US$3.2t | US$143.00 | PE73x | E24.1% | 0.03% | Semiconductors | ||
NU | US$14.63 | 1.2% | 110.2% | US$69.1b | US$14.11 | PB10.1x | E27.3% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BX | US$141.96 | 5.4% | 40.7% | US$170.1b | US$134.89 | PE54.5x | E26.6% | 2.4% | Diversified Financials | ||
PDD | US$100.00 | -33.8% | 23.8% | US$194.2b | US$201.64 | PE12.4x | E20.9% | n/a | Retail | ||
CG | US$39.81 | -4.1% | 31.2% | US$14.3b | US$47.73 | PS5.1x | E22.0% | 3.5% | Diversified Financials | ||
SMCI | US$562.51 | -9.8% | 120.5% | US$35.9b | US$884.64 | PE27.3x | E28.1% | n/a | Tech | ||
OWL | US$17.47 | -2.2% | 55.7% | US$25.4b | US$20.27 | PE106.3x | E89.8% | 4.1% | Diversified Financials | ||
SN | US$89.30 | -1.2% | 153.9% | US$12.6b | US$102.42 | PE50.9x | E24.3% | n/a | Consumer Durables | ||
DASH | US$128.62 | -0.7% | 63.8% | US$53.0b | US$142.94 | PS5.5x | E58.1% | n/a | Consumer Services | ||
NTNX | US$52.93 | 1.8% | 72.7% | US$13.2b | US$70.97 | PS6.2x | E85.2% | n/a | Software | ||
VRT | US$78.06 | -1.0% | 104.5% | US$29.5b | US$101.77 | PE58.7x | E29.9% | 0.1% | Capital Goods | ||
PTC | US$175.95 | -0.2% | 20.9% | US$21.3b | US$198.66 | PE71.6x | E23.9% | n/a | Software | ||
ALNY | US$269.14 | -1.9% | 40.4% | US$35.0b | US$282.72 | PS14.7x | E65.2% | n/a | Pharmaceuticals & Biotech | ||
ZS | US$197.82 | 1.2% | 40.0% | US$30.1b | US$230.67 | PS14.7x | E45.0% | n/a | Software | ||
SPOT | US$336.07 | -2.5% | 137.9% | US$68.8b | US$391.32 | PE129.7x | E29.6% | n/a | Media | ||
TER | US$133.00 | -0.7% | 27.2% | US$22.2b | US$143.95 | PE43.8x | E22.7% | 0.4% | Semiconductors | ||
RYAN | US$64.10 | -1.1% | 35.6% | US$16.8b | US$65.98 | PE98.4x | E61.1% | 0.7% | Insurance | ||
ARM | US$128.90 | -2.6% | n/a | US$142.1b | US$133.85 | PE318.6x | E32.4% | n/a | Semiconductors | ||
MPWR | US$912.25 | -0.5% | 84.7% | US$45.6b | US$945.27 | PE108.2x | E23.4% | 0.5% | Semiconductors | ||
CRWD | US$265.87 | -0.3% | 84.6% | US$66.1b | US$334.42 | PE491.4x | E31.0% | n/a | Software |